Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report

•Ticagrelor antithrombotic treatment can cause a significant increase in everolimus blood concentration, which can lead to severe immunosuppression, increasing the development of opportunistic infections.•Our case demonstrates that Stenotrophomonas maltophilia hemorrhagic pulmonary infection can occ...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings Vol. 56; no. 5; pp. 1192 - 1195
Main Authors: Juhász, Marianna, Antal, Bence, Herczeg, Gabriella, Nemes, Balázs, Fülesdi, Béla, Végh, Tamás
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-06-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Ticagrelor antithrombotic treatment can cause a significant increase in everolimus blood concentration, which can lead to severe immunosuppression, increasing the development of opportunistic infections.•Our case demonstrates that Stenotrophomonas maltophilia hemorrhagic pulmonary infection can occur without leukopenia and is independent of S. maltophilia bloodstream infection.•Rapid onset of thrombocytopenia associated with S. maltophilia infection and concomitant ticagrelor treatment can lead to hemorrhagic pneumonia.•Not only dyspnea and thrombocytopenia but also severe hyperkalemia, elevated concentrations of creatine kinase, lactate dehydrogenase, C-reactive protein, and interleukin-6 may indicate hemorrhagic pneumonia Pneumonia is a common nosocomial complication in transplant patients. Stenotrophomonas maltophilia is recognized as a common cause and is typically seen in immunocompromised and critically ill patients. S. maltophilia, a nonfermenting gram-negative rod, ranks as the third most common nosocomial pathogen, following Pseudomonas aeruginosa and Acinetobacter. The bacteria are frequently found in environmental sources and are prevalent in healthcare facilities, including in tap water faucets, shower outlets, air-cooling systems, intravenous fluids, catheters, dialysis machines, and oxygen humidifiers. This bacterium possesses the ability to rapidly form biofilms, enabling it to colonize new surfaces in less than 24 hours. While S. maltophilia generally exhibits low virulence, there remains uncertainty among many clinicians regarding whether it is merely a colonizer or the primary cause of infection. Although S. maltophilia infections are rare in immunocompetent individuals, the species is increasingly recognized as an opportunistic pathogen in vulnerable populations such as those with cystic fibrosis, cancer, and other conditions leading to immunosuppression. S. maltophilia now recognized as a causative agent in various clinical syndromes, primarily affecting the lungs and bloodstream. We present a case of S. maltophilia-associated lung infection in a kidney transplant recipient, emphasizing the significance of underlying diseases and associated signs and symptoms.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0041-1345
1873-2623
1873-2623
DOI:10.1016/j.transproceed.2024.05.016